Retatrutide is an investigational triple incretin receptor agonist under clinical development by Eli Lilly, whilst 5-Amino-1MQ is a research chemical targeting the NNMT enzyme
For more details on handling and preserving your research materials, check out our peptide storage best practices
All product information on this website is for educational purposes only
Distinct regulation of adiponutrin/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes

Scientific and Official Sources PubChem: BPC-157 identity, synonyms, molecular formula and mass Sikiric and colleagues: early published BPC-157 research ClinicalTrials.gov: PCO-02 BPC-157 safety and pharmacokinetics study Lee and colleagues: two-participant BPC-157 intravenous pilot study McGuire and colleagues: narrative review of BPC-157 evidence and risk World Anti-Doping Agency: 2026 Prohibited List MHRA: Borderline products and how to tell if a product is a medicine Human Medicines Regulations 2012: Regulation 279 United States FDA: safety risks associated with certain bulk substances, including BPC-157 United States FDA: BPC-157-related bulk-substance briefing document CAP Code Section 12: Medicines and health-related products Health and Safety Executive: UK REACH Health and Safety Executive: Safety Data Sheets and COSHH Health and Safety Executive: COSHH risk assessment Cox and colleagues: identification and analytical detection of BPC-157 in confiscated material

At 9 mg/mL, benzyl alcohol works by disrupting bacterial cell membranes, preventing microbial growth from taking hold inside the vial